Holen Sie sich die Stockscreener-App
22.65
4.31%
0.96
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ENOV?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$21.69
Offen:
$22.14
24-Stunden-Volumen:
523.43K
Relative Volume:
0.50
Marktkapitalisierung:
$1.30B
Einnahmen:
$2.25B
Nettoeinkommen (Verlust:
$-1.18B
KGV:
-1.0946
EPS:
-20.6926
Netto-Cashflow:
$19.92M
1W Leistung:
+2.33%
1M Leistung:
-11.17%
6M Leistung:
-25.43%
1J Leistung:
-40.79%
1-Tages-Spanne:
$21.59
$22.87
1-Wochen-Bereich:
$21.48
$23.60
52-Wochen-Spanne:
$21.00
$38.19
Enovis Corp Stock (ENOV) Company Profile
Firmenname
Enovis Corp
Sektor
Branche
Telefon
(302) 252-9160
Adresse
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
22.66 | 1.24B | 2.25B | -1.18B | 19.92M | -20.69 |
ABT
Abbott Laboratories
|
102.47 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.77 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.72 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.40 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-06 | Eingeleitet | BTIG Research | Buy |
| 2024-10-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-06-13 | Eingeleitet | JP Morgan | Neutral |
| 2024-02-13 | Eingeleitet | Stephens | Overweight |
| 2024-01-22 | Eingeleitet | UBS | Buy |
| 2024-01-03 | Eingeleitet | William Blair | Outperform |
| 2023-12-15 | Bestätigt | Needham | Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-06-26 | Eingeleitet | Needham | Buy |
| 2023-05-12 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-10-11 | Eingeleitet | Goldman | Buy |
| 2022-09-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-09-12 | Eingeleitet | Evercore ISI | Outperform |
| 2022-06-28 | Eingeleitet | Argus | Hold |
| 2022-06-27 | Fortgesetzt | Loop Capital | Buy |
| 2022-06-16 | Eingeleitet | Wells Fargo | Equal Weight |
Alle ansehen
Enovis Corp Aktie (ENOV) Neueste Nachrichten
Enovis Corporation (ENOV) Stock Price Quote Today & Current Price Chart - Capital.com
Breakout Zone: What is Enovis Corporations 5 year growth outlookMarket Sentiment Review & Consistent Profit Trade Alerts - baoquankhu1.vn
Trading Recap: What is Enovis Corporations 5 year growth outlookMarket Trend Report & Risk Controlled Daily Plans - baoquankhu1.vn
Enovis (NYSE:ENOV) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Enovis, Neogen, Humana, LifeStance Health Group, and Hims & Hers Health stocks trade down, what you need to know - MSN
Enovis, Neogen, Humana, LifeStance Health Group, and Hims & Hers Health Stocks Trade Down, What You Need To Know - Yahoo Finance
Press Release: Enovis Announces First Quarter 2025 Results - 富途牛牛
[SCHEDULE 13G/A] Enovis CORP Amended Passive Investment Disclosure - Stock Titan
Wall Street analysts see a 100.71% upside in Enovis (ENOV): Can the stock really move this high? - MSN
Enovis Delivers 7% Sales Growth in Q2, Raises Full-Year Outlook - MSN
DAVENPORT & Co LLC Cuts Stock Holdings in Enovis Corporation $ENOV - MarketBeat
Enovis Corporation (NYSE:ENOV) Q4 2025 earnings call transcript - MSN
Wall Street experts predict Enovis (ENOV) could climb by 100.71%: Is such a surge truly possible for the stock? - bitget.com
Wall Street Analysts See a 100.71% Upside in Enovis (ENOV): Can the Stock Really Move This High? - Yahoo Finance
Enovis (NYSE:ENOV) Stock Rating Lowered by Wall Street Zen - MarketBeat
Enovis Corporation (NYSE:ENOV) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Tranche Update on Enovis Corporation's Equity Buyback Plan announced on February 16, 2018. - marketscreener.com
Wells Fargo Sticks to Its Buy Rating for Enovis (ENOV) - The Globe and Mail
Enovis (NYSE:ENOV) Rating Increased to Strong-Buy at Wells Fargo & Company - MarketBeat
UBS reiterates Enovis stock Buy rating on growth outlook By Investing.com - Investing.com Australia
UBS reiterates Enovis stock Buy rating on growth outlook - Investing.com
Enovis (ENOV) to report earnings tomorrow: Here is what to expect - MSN
Wells Fargo Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $42 - 富途牛牛
Signal Recap: Can Enovis Corporation maintain its current growth rate2026 Sector Review & Trade Opportunity Analysis - baoquankhu1.vn
Engert Oliver, chief administrative officer, buys Enovis Corp (ENOV) shares By Investing.com - Investing.com South Africa
Insider Buying: Oliver Engert Acquires Shares of Enovis Corp (EN - GuruFocus
Oliver Engert Buys 1,000 Shares of Enovis (NYSE:ENOV) Stock - MarketBeat
Engert Oliver, chief administrative officer, buys Enovis Corp (ENOV) shares - Investing.com
Enovis tops profit expectations but revenue falls short - MSN
[Form 4] Enovis CORP Insider Trading Activity - Stock Titan
Invenomic Capital Management LP Has $21.62 Million Holdings in Enovis Corporation $ENOV - MarketBeat
ENOV SEC FilingsEnovis Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Enovis Corporation $ENOV Stake Lowered by Dorsey Asset Management LLC - MarketBeat
How The Enovis (ENOV) Story Is Shifting Around Growth Margins And Cash Generation - Yahoo Finance
Enovis (NYSE:ENOV) Stock Rating Upgraded by Wall Street Zen - MarketBeat
ESAB,ENOV Options - Finviz
Engert Oliver, chief administrative officer at Enovis, buys $23,930 in ENOV By Investing.com - Investing.com South Africa
Enovis Corporation (ENOV): Orthopedic innovation and growth potential drive analyst confidence - MSN
Top Enovis Insider Makes Bold Move With Fresh Stock Purchase - TipRanks
Engert Oliver, chief administrative officer at Enovis, buys $23,930 in ENOV - Investing.com Australia
Enovis (ENOV) CAO Oliver Engert buys 1,000 shares in open-market trade - Stock Titan
Barclays PLC Lowers Stake in Enovis Corporation $ENOV - MarketBeat
Enovis (ENOV) Is Down 5.5% After 2025 Loss And 2026 Revenue Outlook UpdateHas The Bull Case Changed? - simplywall.st
Enovis (NYSE:ENOV) Insider Oliver Engert Purchases 750 Shares - MarketBeat
Enovis (ENOV) CFO awarded 47,974 RSUs as 3,167 shares withheld for taxes - Stock Titan
Finanzdaten der Enovis Corp-Aktie (ENOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):